GlassScriptPhysician profile
Donald A Newman
NPI 1316929482
$326.66
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $160 · 2021: $35.35 · 2022: $23.52.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $102.44 | 2020 | |
| Glaxosmithkline, LLC. | $75.05 | 2019-2020 | |
| Omeros Corporation | $39.67 | 2019-2020 | |
| Glaukos Corporation | $23.52 | 2022 | |
| Abbvie INC. | $21.81 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $18.11 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.54 | 2021 | |
| Sanofi Pasteur INC. | $13.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.